Eccentric (ECC) cycling, compared to traditional concentric cycling, has been shown to improve muscle strength and neuromuscular control at a lower metabolic cost. Despite the popularity of this exercise in the sports and rehabilitation contexts, there is a gap in our knowledge of which muscles are behaving eccentrically during ECC cycling. To this end, we used a musculoskeletal model and computer simulations to calculate joint kinematics and muscle lengths during ECC cycling. Movements were recorded using 3D motion capture technology while cycling eccentrically on a custom-built semi-recumbent ergometer. The software Opensim was used to calculate joint kinematics and muscle lengths from recorded movements. We found that among the primary knee extensors, it was predominantly the Vastii muscles that acted eccentrically in the ECC cycling phase, with other lower limb muscles showing mixed eccentric/concentric activation. Additionally, the muscle force-length and force-velocity factors in the ECC phase suggest that changes to the participant's pose and pedaling speed may elicit larger active muscle forces. Our work provides an interesting application of musculoskeletal modeling to ECC cycling, and an alternative way to help understand in-vivo muscle mechanics during this activity.

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC40787.2023.10340580DOI Listing

Publication Analysis

Top Keywords

ecc cycling
20
lower limb
8
limb muscles
8
cycling
8
cycling musculoskeletal
8
musculoskeletal modeling
8
eccentrically ecc
8
calculate joint
8
joint kinematics
8
kinematics muscle
8

Similar Publications

Background: Emergency medical services attend out-of-hospital cardiac arrests all across Australia. Resuscitation by emergency medical services is attempted in nearly half of all cases. However, resuscitation skills can degrade over time without adequate exposure, which negatively impacts patient survival.

View Article and Find Full Text PDF

Purpose: SWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly diagnosed advanced biliary tract cancers (BTCs).

Methods: Patients with newly diagnosed locally advanced unresectable or metastatic BTC, including intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC) and gallbladder carcinoma (GBC), were randomly assigned 2:1 to either GAP (gemcitabine 800 mg/m, cisplatin 25 mg/m, and nab-paclitaxel 100 mg/m intravenously once per day on days 1 and 8 of a 21-day cycle) or GC (gemcitabine 1,000 mg/m and cisplatin 25 mg/m intravenously once per day on days 1 and 8 of a 21-day cycle).

Results: Among 452 randomly assigned participants, 441 were eligible and analyzable, 67% with ICC, 16% with GBC, and 17% with ECC.

View Article and Find Full Text PDF

Background: Joint stiffness endurance is considered essential in many sports events. We previously reported that reduced joint stiffness due to repetitive hopping was associated with reduced active muscle stiffness. However, the determinants of active muscle stiffness endurance were unknown.

View Article and Find Full Text PDF

Ultrasound (US) based radiomics is susceptible to variations in scanners, sonographers. To retrospectively investigate the feasibility of an adapted cycle generative adversarial networks (CycleGAN) in the style transfer to improve US based radiomics in the prediction of lymph node metastasis (LNM) with images from multiple scanners for patients with early cervical cancer (ECC). The CycleGAN was firstly trained to transfer paired US phantom images from one US device to another one; the model was then further trained and tested with clinical US images of ECC by transferring images from four US devices to one specific device; finally, the adapted model was tested with its effects on the radiomics feature harmonization and accuracy of LNM prediction in US based radiomics for ECC patients.

View Article and Find Full Text PDF
Article Synopsis
  • Photodynamic therapy (PDT) can induce necrosis and apoptosis in extrahepatic cholangiocarcinoma (ECC) cells, but its effectiveness is limited due to shallow tissue penetration and weak therapeutic impact, making complete tumor eradication challenging.
  • This study investigates how ferroptosis, a type of cell death, interacts with Hematoporphyrin-mediated PDT, analyzing the effects of various ferroptosis inducers on the treatment's effectiveness.
  • Results show that combining PDT with ferroptosis inducers like Lenvatinib or Erastin increases reactive oxygen species levels, decreases antioxidant levels, and enhances cell death in cholangiocarcinoma cells, suggesting a promising strategy to improve PDT outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!